The emergence of therapeutic agents like semaglutide and tirzepatide has transformed the approach to treating type 2 diabetes and promoting weight reduction. While both drugs share a similar mechanism of action – mimicking the effects of the natural hormone GLP-1 – tirzepatide possesses a distinct advantage: it’s a dual agonist, targeting bot